Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22580560

Pramipexole Extended Release: In Parkinson's Disease

Author
CHWIEDUK, Claudine M1 ; CURRAN, Monique P1
[1] Adis, a Wolters Kluwer Business, Auckland, New Zealand
Source

CNS drugs. 2010, Vol 24, Num 4, pp 327-336, 10 p ; ref : 25 ref

ISSN
1172-7047
Scientific domain
Pharmacology drugs; Psychology, psychopathology, psychiatry
Publisher
Adis International, Auckland / Adis International, Hong Kong
Publication country
New Zealand
Document type
Article
Language
English
Keyword (fr)
Antiparkinsonien Article synthèse Effet secondaire Efficacité traitement Fiche technique Forme commerciale Forme libération contrôlée Homme Indication Maladie de Parkinson Mécanisme action Médicament Neuroprotecteur Pharmacocinétique Pharmacothérapie Posologie Pramipexole Toxicité Pharmacodynamie Agoniste Forme pharmaceutique Maladie dégénérative Pathologie de l'encéphale Pathologie du système nerveux central Pathologie du système nerveux Récepteur dopaminergique D2 Stimulant dopaminergique Syndrome extrapyramidal Traitement
Keyword (en)
Antiparkinson agent Review Secondary effect Treatment efficiency Technical card Commercial form Controlled release form Human Indication Parkinson disease Mechanism of action Drug Neuroprotective agent Pharmacokinetics Pharmacotherapy Posology Pramipexole Toxicity Pharmacodynamics Agonist Dosage form Degenerative disease Cerebral disorder Central nervous system disease Nervous system diseases D2 Dopamine receptor Dopamine agonist Extrapyramidal syndrome Treatment
Keyword (es)
Antiparkinsoniano Artículo síntesis Efecto secundario Eficacia tratamiento Ficha técnica Forma comercial Forma liberación controlada Hombre Indicación Parkinson enfermedad Mecanismo acción Medicamento Neuroprotector Farmacocinética Farmacoterapia Posología Pramipexol Toxicidad Farmacodinámica Agonista Forma farmacéutica Enfermedad degenerativa Encéfalo patología Sistema nervosio central patología Sistema nervioso patología Receptor dopaminérgico D2 Estimulante dopaminérgico Extrapiramidal síndrome Tratamiento
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B10 Neuroprotective agent

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17A Nervous system (semeiology, syndromes) / 002B17A01 Nervous system as a whole

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17G Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C13 Organic mental disorders. Neuropsychology

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03M Organic mental disorders. Neuropsychology

Discipline
Neurology Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
22580560

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web